96 related articles for article (PubMed ID: 7482437)
1. Effect of in vitro incorporation of prostanoid precursors, superoxide radical and hydrogen peroxide on platelet function.
Akinshola BE; Verma PS; Taylor RE
Thromb Res; 1995 Aug; 79(4):343-51. PubMed ID: 7482437
[TBL] [Abstract][Full Text] [Related]
2. Modulation of platelet function by reactive oxygen metabolites.
Ambrosio G; Golino P; Pascucci I; Rosolowsky M; Campbell WB; DeClerck F; Tritto I; Chiariello M
Am J Physiol; 1994 Jul; 267(1 Pt 2):H308-18. PubMed ID: 8048596
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of platelet function by superoxide anion.
Handin RI; Karabin R; Boxer GJ
J Clin Invest; 1977 May; 59(5):959-65. PubMed ID: 192766
[TBL] [Abstract][Full Text] [Related]
4. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
Zahavi M; Zahavi J; Kakkar VV
Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
[TBL] [Abstract][Full Text] [Related]
5. Eskimo plasma constituents, dihomo-gamma-linolenic acid, eicosapentaenoic acid and docosahexaenoic acid inhibit the release of atherogenic mitogens.
Smith DL; Willis AL; Nguyen N; Conner D; Zahedi S; Fulks J
Lipids; 1989 Jan; 24(1):70-5. PubMed ID: 2545997
[TBL] [Abstract][Full Text] [Related]
6. The effect of dihomogammalinolenic acid on platelet aggregation and prostaglandin release, erythrocyte membrane fatty acids and serum lipids: evidence for defects in PGE1 synthesis and delta 5-desaturase activity in insulin-dependent diabetics.
Mikhailidis DP; Kirtland SJ; Barradas MA; Mahadeviah S; Dandona P
Diabetes Res; 1986 Jan; 3(1):7-12. PubMed ID: 2937601
[TBL] [Abstract][Full Text] [Related]
7. Oxygen-radical-mediated lipid peroxidation and inhibition of ADP-induced platelet aggregation.
Ohyashiki T; Kobayashi M; Matsui K
Arch Biochem Biophys; 1991 Jul; 288(1):282-6. PubMed ID: 1898021
[TBL] [Abstract][Full Text] [Related]
8. Modulation of platelet cyclic nucleotide content by PGE1 and the prostaglandin endoperoxide PGG2.
Miller OV; Gorman RR
J Cyclic Nucleotide Res; 1976; 2(2):79-87. PubMed ID: 177467
[TBL] [Abstract][Full Text] [Related]
9. Effect of heparin and dihydroergotamine on platelet adenosine-3',5'-cyclic monophosphate.
Zahavi M; Welzel D; Wolf H; Honey A; Kakkar VV
Arzneimittelforschung; 1987 Jun; 37(6):669-74. PubMed ID: 2822055
[TBL] [Abstract][Full Text] [Related]
10. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
Patscheke H; Stegmeier K
Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
[TBL] [Abstract][Full Text] [Related]
11. Hispidulin, a natural flavone, inhibits human platelet aggregation by increasing cAMP levels.
Bourdillat B; Delautier D; Labat C; Benveniste J; Potier P; Brink C
Eur J Pharmacol; 1988 Feb; 147(1):1-6. PubMed ID: 2836213
[TBL] [Abstract][Full Text] [Related]
12. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
[TBL] [Abstract][Full Text] [Related]
13. The effect of pyridoxal-5-phosphate on the inhibition of platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation in human platelets.
Zahavi M; Zahavi J; Kakkar VV
Life Sci; 1984 Oct; 35(14):1497-503. PubMed ID: 6090838
[TBL] [Abstract][Full Text] [Related]
14. Uptake and effect on arachidonic acid oxygenation of some icosaenoic acids in human platelets.
Lagarde M; Drouot B; Guichardant M; Dechavanne M
Biomed Biochim Acta; 1984; 43(8-9):S319-22. PubMed ID: 6097236
[TBL] [Abstract][Full Text] [Related]
15. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam.
Romstedt K; Huzoor-Akbar
Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062
[TBL] [Abstract][Full Text] [Related]
16. Competitive antagonism at thromboxane receptors in human platelets.
Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
[TBL] [Abstract][Full Text] [Related]
17. Relation between the inhibition of aggregation and the concentration of cAMP in human and rat platelets.
Michel H; Caen JP; Born GV; Miller R; D'Auriac GA; Meyer P
Br J Haematol; 1976 May; 33(1):27-38. PubMed ID: 178342
[TBL] [Abstract][Full Text] [Related]
18. Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells.
Eigenthaler M; Nolte C; Halbrügge M; Walter U
Eur J Biochem; 1992 Apr; 205(2):471-81. PubMed ID: 1315268
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
20. Dihomogammalinolenic acid, but not eicosapentaenoic acid, activates washed human platelets.
Siess W; Siegel FL; Lapetina EG
Biochim Biophys Acta; 1984 Sep; 801(2):265-76. PubMed ID: 6089912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
